Where is Akamis Bio headquartered?

Akamis Bio is located in Abingdon, Oxfordshire.

Who invested in Akamis Bio?

Akamis Bio has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Akamis Bio?

Akamis Bio closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

akamisbio.com

Akamis Bio

Akamis Bio is a clinical-stage oncology company.

Business Model:

Revenue: $0

Employees: 51-200

Rankings

Industries / Tags:

Biotechnology

Health Care

Therapeutics

Detailed Akamis Bio Information

General Information

Geographic Data

Address:

City: Abingdon

State: Oxfordshire

Zip:

Country: United Kingdom

Financial Info

Stage:

debt financing

Raised Last:

$30M

Raised Total:

$132M

Social

Twitter

Crunchbase

Metrics

7,940,165Website Global Rank

489Website Monthly Traffic

Twitter Followers

Description

Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient&s;s immune system to recognize, attack, and clear their cancer.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
5/2015	Series C	6	$38.8M	Imperial Innovations Invesco Lundbeckfonden Ventures Mercia Asset Management PLC SR One Woodford Investment Management Imperial Innovations Invesco Lundbeckfonden Ventures Mercia Asset Management PLC SR One Woodford Investment Management
9/2011	Grant		$2.9M
12/2017	Venture Round	1	$15M	Bristol Myers Squibb Bristol Myers Squibb
1/2013	Grant		$3.3M
1/2007	Seed Round		-
7/2012	Series B	4	$34.1M	Imperial Innovations SR One Lundbeckfonden Ventures Invesco Imperial Innovations
1/2023	Debt Financing		$0	ARCH Venture Partners Parker Institute for Cancer Immunotherapy Westlake Village BioPartners ARCH Venture Partners Parker Institute for Cancer Immunotherapy Westlake Village BioPartners
3/2010	Series A	2	$8.4M	Invesco Imperial Innovations
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.
1/2023	Debt Financing	3	$30M	ARCH Venture Partners Parker Institute for Cancer Immunotherapy Westlake Village BioPartners ARCH Venture Partners Parker Institute for Cancer Immunotherapy Westlake Village BioPartners
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.
1/2007	Seed Round		-

Acquisitions

Announced Date	Name	Price
12/2010	Hybrid BioSystems

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details